Page last updated: 2024-10-21

edelfosine and Carcinoma, Lewis Lung

edelfosine has been researched along with Carcinoma, Lewis Lung in 1 studies

edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad, I1
Filep, JJ1
Franklin, JC1
Janoff, AS1
Masters, GR1
Pattassery, J1
Peters, A1
Schupsky, JJ1
Zha, Y1
Mayhew, E1

Other Studies

1 other study available for edelfosine and Carcinoma, Lewis Lung

ArticleYear
Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
    Cancer research, 1997, May-15, Volume: 57, Issue:10

    Topics: Animals; Antineoplastic Agents; Ascitic Fluid; Carcinoma, Lewis Lung; Drug Screening Assays, Antitum

1997